STOCK TITAN

[FWP] Morgan Stanley Free Writing Prospectus

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) has filed a Form 144 indicating the planned disposition of 1,500 common shares through Wells Fargo Clearing Services on or about 01 July 2025. The filing places the aggregate market value of the proposed sale at $22,133.80, based on the prevailing market price at the time of preparation. With 18,350,801 shares outstanding, the contemplated sale represents roughly 0.008% of total shares—an immaterial slice of the company’s equity base.

The seller is identified as the Richard D Moss Revocable Trust (and related individual accounts). The securities were originally acquired on 06 May 2024 as restricted share grants/compensation, meaning the shares are now coming off restriction and becoming eligible for public resale under Rule 144.

Recent selling pattern: The same trust (and Richard D Moss personally) has reported 39,734 shares sold over the last three months, generating cumulative gross proceeds of approximately $479,000 (sum of individual transactions listed). The filing does not cite any material non-public information or trading plan details; the signatory attests to compliance with Rule 144 and the absence of undisclosed adverse information.

For investors, the transaction signals continued insider liquidity activity but, taken alone, is not large enough to affect the float or exert meaningful market pressure. Nevertheless, the frequency of sales may be interpreted as a modestly negative sentiment indicator should the pattern persist.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) ha presentato un modulo Form 144 indicando la prevista cessione di 1.500 azioni ordinarie tramite Wells Fargo Clearing Services intorno al 01 luglio 2025. La documentazione stima il valore di mercato complessivo della vendita proposta in 22.133,80 $, basandosi sul prezzo di mercato vigente al momento della preparazione. Con 18.350.801 azioni in circolazione, la vendita prevista rappresenta circa lo 0,008% del totale delle azioni, una quota trascurabile della base azionaria della società.

Il venditore è identificato come il Richard D Moss Revocable Trust (e conti individuali correlati). I titoli sono stati originariamente acquisiti il 06 maggio 2024 come concessioni di azioni vincolate/compensi, il che significa che ora le azioni stanno uscendo dalle restrizioni e diventano idonee per la rivendita pubblica secondo la Regola 144.

Andamento recente delle vendite: Lo stesso trust (e Richard D Moss personalmente) ha segnalato la vendita di 39.734 azioni negli ultimi tre mesi, generando proventi lordi cumulativi di circa 479.000 $ (somma delle singole transazioni elencate). Il modulo non cita informazioni riservate rilevanti o dettagli di un piano di trading; il firmatario attesta la conformità alla Regola 144 e l’assenza di informazioni negative non divulgate.

Per gli investitori, la transazione indica una continua attività di liquidità da parte degli insider ma, da sola, non è sufficientemente significativa da influenzare il flottante o esercitare una pressione di mercato rilevante. Tuttavia, la frequenza delle vendite potrebbe essere interpretata come un indicatore di sentiment moderatamente negativo se il trend dovesse proseguire.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) ha presentado un Formulario 144 indicando la disposición planeada de 1,500 acciones comunes a través de Wells Fargo Clearing Services alrededor del 01 de julio de 2025. La presentación estima el valor de mercado agregado de la venta propuesta en $22,133.80, basado en el precio de mercado vigente al momento de la preparación. Con 18,350,801 acciones en circulación, la venta contemplada representa aproximadamente el 0.008% del total de acciones, una porción insignificante de la base accionaria de la compañía.

El vendedor es identificado como el Richard D Moss Revocable Trust (y cuentas individuales relacionadas). Los valores fueron adquiridos originalmente el 06 de mayo de 2024 como concesiones de acciones restringidas/compensación, lo que significa que las acciones ahora están saliendo de restricción y se vuelven elegibles para reventa pública bajo la Regla 144.

Patrón reciente de ventas: El mismo trust (y Richard D Moss personalmente) ha reportado la venta de 39,734 acciones en los últimos tres meses, generando ingresos brutos acumulados de aproximadamente $479,000 (suma de transacciones individuales listadas). La presentación no menciona información material no pública ni detalles de planes de negociación; el firmante certifica el cumplimiento con la Regla 144 y la ausencia de información adversa no divulgada.

Para los inversores, la transacción señala una actividad continua de liquidez de insiders, pero por sí sola no es lo suficientemente grande como para afectar el flotante o ejercer presión significativa en el mercado. Sin embargo, la frecuencia de las ventas puede interpretarse como un indicador de sentimiento modestamente negativo si el patrón persiste.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR)가 약 2025년 7월 1일경 Wells Fargo Clearing Services를 통해 1,500주 보통주 매각 계획을 나타내는 Form 144를 제출했습니다. 제출서류는 작성 시점의 시장 가격을 기준으로 제안된 매각의 총 시장 가치를 $22,133.80로 산정했습니다. 총 18,350,801주가 발행된 상태에서 이번 매각은 전체 주식의 약 0.008%에 해당하며, 회사 지분의 미미한 부분입니다.

매도인은 Richard D Moss Revocable Trust (및 관련 개인 계좌)로 확인됩니다. 해당 증권은 2024년 5월 6일 제한된 주식 보조금/보상으로 처음 취득되었으며, 이는 현재 주식이 제한에서 해제되어 Rule 144에 따라 공개 재판매가 가능해졌음을 의미합니다.

최근 매도 동향: 동일한 트러스트(및 Richard D Moss 개인)는 지난 3개월간 39,734주를 매도해 총 약 $479,000의 총 수익을 기록했습니다(개별 거래 합산). 제출서류에는 중요 비공개 정보나 거래 계획 세부사항이 언급되어 있지 않으며, 서명자는 Rule 144 준수 및 미공개 불리한 정보 부재를 확인했습니다.

투자자들에게 이번 거래는 내부자 지속적인 유동성 활동을 시사하지만 단독으로는 유통 주식 수에 영향을 미치거나 시장에 큰 압력을 가할 정도는 아닙니다. 다만, 매도 빈도가 지속된다면 다소 부정적인 심리 지표로 해석될 수 있습니다.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) a déposé un formulaire 144 indiquant la cession prévue de 1 500 actions ordinaires via Wells Fargo Clearing Services aux alentours du 1er juillet 2025. Le dépôt évalue la valeur marchande totale de la vente proposée à 22 133,80 $, basée sur le cours du marché en vigueur au moment de la préparation. Avec 18 350 801 actions en circulation, la vente envisagée représente environ 0,008% du total des actions – une part négligeable de la base capitalistique de la société.

Le vendeur est identifié comme le Richard D Moss Revocable Trust (et les comptes individuels associés). Les titres ont été initialement acquis le 6 mai 2024 sous forme de subventions d’actions restreintes/rémunération, ce qui signifie que les actions sont désormais libérées de restrictions et deviennent éligibles à la revente publique selon la règle 144.

Modèle récent de ventes : Le même trust (et Richard D Moss personnellement) a déclaré avoir vendu 39 734 actions au cours des trois derniers mois, générant des produits bruts cumulés d’environ 479 000 $ (somme des transactions individuelles listées). Le dépôt ne mentionne aucune information confidentielle importante ni détails de plan de trading ; le signataire atteste de la conformité à la règle 144 et de l’absence d’informations défavorables non divulguées.

Pour les investisseurs, cette transaction signale une activité continue de liquidité des initiés, mais prise isolément, elle n’est pas assez importante pour affecter le flottant ou exercer une pression significative sur le marché. Néanmoins, la fréquence des ventes pourrait être interprétée comme un indicateur de sentiment modérément négatif si cette tendance se poursuit.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) hat ein Formular 144 eingereicht, das die geplante Veräußerung von 1.500 Stammaktien über Wells Fargo Clearing Services etwa am 01. Juli 2025 anzeigt. Die Einreichung beziffert den aggregierten Marktwert des vorgeschlagenen Verkaufs auf 22.133,80 $, basierend auf dem zum Zeitpunkt der Erstellung vorherrschenden Marktpreis. Bei 18.350.801 ausstehenden Aktien entspricht der geplante Verkauf etwa 0,008% der Gesamtaktien – ein unerheblicher Anteil am Eigenkapital des Unternehmens.

Der Verkäufer wird als Richard D Moss Revocable Trust (und zugehörige Einzelkonten) identifiziert. Die Wertpapiere wurden ursprünglich am 06. Mai 2024 als eingeschränkte Aktienzuteilungen/Vergütung erworben, was bedeutet, dass die Aktien nun von Beschränkungen befreit werden und gemäß Regel 144 öffentlich weiterverkauft werden dürfen.

Jüngstes Verkaufsmuster: Derselbe Trust (und Richard D Moss persönlich) hat in den letzten drei Monaten 39.734 Aktien verkauft und damit kumulierte Bruttoerlöse von etwa 479.000 $ erzielt (Summe der aufgeführten Einzeltransaktionen). Die Einreichung nennt keine wesentlichen nicht öffentlichen Informationen oder Details zu einem Handelsplan; der Unterzeichner bestätigt die Einhaltung von Regel 144 und das Fehlen nicht offengelegter negativer Informationen.

Für Investoren signalisiert die Transaktion eine fortgesetzte Liquiditätsaktivität von Insidern, ist jedoch für sich allein genommen nicht groß genug, um den Streubesitz zu beeinflussen oder nennenswerten Marktdruck auszuüben. Dennoch könnte die Häufigkeit der Verkäufe als leicht negatives Sentiment interpretiert werden, sollte das Muster anhalten.

Positive
  • Minimal dilution risk: 1,500 shares represent only 0.008% of outstanding stock, posing no threat to share count or control.
  • Regulatory transparency: Filing under Rule 144 provides timely disclosure, allowing investors to track insider activity.
Negative
  • Ongoing insider selling: Approximately 39,734 shares sold in the last three months suggests sustained desire to reduce exposure.
  • Potential sentiment drag: Repeated sales by a revocable trust linked to an insider may be interpreted as weakened confidence among management-related parties.

Insights

TL;DR – Small sale, but ongoing insider disposition trend warrants monitoring.

The Form 144 registers a routine sale of 1,500 shares (<0.01% of NATR’s float) by the Richard D Moss Revocable Trust. While the quantum is trivial, the trust has liquidated nearly 40k shares in the preceding quarter. Repeated insider selling can telegraph reduced confidence or simple diversification. No price-sensitive information is asserted, and the sale stems from previously granted restricted stock, so the filing appears procedural. Impact on valuation or liquidity is negligible; nonetheless, active investors may factor the selling cadence into sentiment screens.

TL;DR – Governance neutral, but cumulative insider sales may influence perception of alignment.

Rule 144 filings provide transparency on affiliate dispositions. The trust’s sale frequency—14 transactions in three months—may raise alignment questions among governance-focused shareholders even though volumes are modest. The certification that no undisclosed adverse information exists is standard. Absent complementary disclosures (trading plan dates, role of Richard D Moss inside NATR), the filing is assessed as routine with minor negative optics rather than a substantive governance event.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) ha presentato un modulo Form 144 indicando la prevista cessione di 1.500 azioni ordinarie tramite Wells Fargo Clearing Services intorno al 01 luglio 2025. La documentazione stima il valore di mercato complessivo della vendita proposta in 22.133,80 $, basandosi sul prezzo di mercato vigente al momento della preparazione. Con 18.350.801 azioni in circolazione, la vendita prevista rappresenta circa lo 0,008% del totale delle azioni, una quota trascurabile della base azionaria della società.

Il venditore è identificato come il Richard D Moss Revocable Trust (e conti individuali correlati). I titoli sono stati originariamente acquisiti il 06 maggio 2024 come concessioni di azioni vincolate/compensi, il che significa che ora le azioni stanno uscendo dalle restrizioni e diventano idonee per la rivendita pubblica secondo la Regola 144.

Andamento recente delle vendite: Lo stesso trust (e Richard D Moss personalmente) ha segnalato la vendita di 39.734 azioni negli ultimi tre mesi, generando proventi lordi cumulativi di circa 479.000 $ (somma delle singole transazioni elencate). Il modulo non cita informazioni riservate rilevanti o dettagli di un piano di trading; il firmatario attesta la conformità alla Regola 144 e l’assenza di informazioni negative non divulgate.

Per gli investitori, la transazione indica una continua attività di liquidità da parte degli insider ma, da sola, non è sufficientemente significativa da influenzare il flottante o esercitare una pressione di mercato rilevante. Tuttavia, la frequenza delle vendite potrebbe essere interpretata come un indicatore di sentiment moderatamente negativo se il trend dovesse proseguire.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) ha presentado un Formulario 144 indicando la disposición planeada de 1,500 acciones comunes a través de Wells Fargo Clearing Services alrededor del 01 de julio de 2025. La presentación estima el valor de mercado agregado de la venta propuesta en $22,133.80, basado en el precio de mercado vigente al momento de la preparación. Con 18,350,801 acciones en circulación, la venta contemplada representa aproximadamente el 0.008% del total de acciones, una porción insignificante de la base accionaria de la compañía.

El vendedor es identificado como el Richard D Moss Revocable Trust (y cuentas individuales relacionadas). Los valores fueron adquiridos originalmente el 06 de mayo de 2024 como concesiones de acciones restringidas/compensación, lo que significa que las acciones ahora están saliendo de restricción y se vuelven elegibles para reventa pública bajo la Regla 144.

Patrón reciente de ventas: El mismo trust (y Richard D Moss personalmente) ha reportado la venta de 39,734 acciones en los últimos tres meses, generando ingresos brutos acumulados de aproximadamente $479,000 (suma de transacciones individuales listadas). La presentación no menciona información material no pública ni detalles de planes de negociación; el firmante certifica el cumplimiento con la Regla 144 y la ausencia de información adversa no divulgada.

Para los inversores, la transacción señala una actividad continua de liquidez de insiders, pero por sí sola no es lo suficientemente grande como para afectar el flotante o ejercer presión significativa en el mercado. Sin embargo, la frecuencia de las ventas puede interpretarse como un indicador de sentimiento modestamente negativo si el patrón persiste.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR)가 약 2025년 7월 1일경 Wells Fargo Clearing Services를 통해 1,500주 보통주 매각 계획을 나타내는 Form 144를 제출했습니다. 제출서류는 작성 시점의 시장 가격을 기준으로 제안된 매각의 총 시장 가치를 $22,133.80로 산정했습니다. 총 18,350,801주가 발행된 상태에서 이번 매각은 전체 주식의 약 0.008%에 해당하며, 회사 지분의 미미한 부분입니다.

매도인은 Richard D Moss Revocable Trust (및 관련 개인 계좌)로 확인됩니다. 해당 증권은 2024년 5월 6일 제한된 주식 보조금/보상으로 처음 취득되었으며, 이는 현재 주식이 제한에서 해제되어 Rule 144에 따라 공개 재판매가 가능해졌음을 의미합니다.

최근 매도 동향: 동일한 트러스트(및 Richard D Moss 개인)는 지난 3개월간 39,734주를 매도해 총 약 $479,000의 총 수익을 기록했습니다(개별 거래 합산). 제출서류에는 중요 비공개 정보나 거래 계획 세부사항이 언급되어 있지 않으며, 서명자는 Rule 144 준수 및 미공개 불리한 정보 부재를 확인했습니다.

투자자들에게 이번 거래는 내부자 지속적인 유동성 활동을 시사하지만 단독으로는 유통 주식 수에 영향을 미치거나 시장에 큰 압력을 가할 정도는 아닙니다. 다만, 매도 빈도가 지속된다면 다소 부정적인 심리 지표로 해석될 수 있습니다.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) a déposé un formulaire 144 indiquant la cession prévue de 1 500 actions ordinaires via Wells Fargo Clearing Services aux alentours du 1er juillet 2025. Le dépôt évalue la valeur marchande totale de la vente proposée à 22 133,80 $, basée sur le cours du marché en vigueur au moment de la préparation. Avec 18 350 801 actions en circulation, la vente envisagée représente environ 0,008% du total des actions – une part négligeable de la base capitalistique de la société.

Le vendeur est identifié comme le Richard D Moss Revocable Trust (et les comptes individuels associés). Les titres ont été initialement acquis le 6 mai 2024 sous forme de subventions d’actions restreintes/rémunération, ce qui signifie que les actions sont désormais libérées de restrictions et deviennent éligibles à la revente publique selon la règle 144.

Modèle récent de ventes : Le même trust (et Richard D Moss personnellement) a déclaré avoir vendu 39 734 actions au cours des trois derniers mois, générant des produits bruts cumulés d’environ 479 000 $ (somme des transactions individuelles listées). Le dépôt ne mentionne aucune information confidentielle importante ni détails de plan de trading ; le signataire atteste de la conformité à la règle 144 et de l’absence d’informations défavorables non divulguées.

Pour les investisseurs, cette transaction signale une activité continue de liquidité des initiés, mais prise isolément, elle n’est pas assez importante pour affecter le flottant ou exercer une pression significative sur le marché. Néanmoins, la fréquence des ventes pourrait être interprétée comme un indicateur de sentiment modérément négatif si cette tendance se poursuit.

Nature’s Sunshine Products, Inc. (NASDAQ: NATR) hat ein Formular 144 eingereicht, das die geplante Veräußerung von 1.500 Stammaktien über Wells Fargo Clearing Services etwa am 01. Juli 2025 anzeigt. Die Einreichung beziffert den aggregierten Marktwert des vorgeschlagenen Verkaufs auf 22.133,80 $, basierend auf dem zum Zeitpunkt der Erstellung vorherrschenden Marktpreis. Bei 18.350.801 ausstehenden Aktien entspricht der geplante Verkauf etwa 0,008% der Gesamtaktien – ein unerheblicher Anteil am Eigenkapital des Unternehmens.

Der Verkäufer wird als Richard D Moss Revocable Trust (und zugehörige Einzelkonten) identifiziert. Die Wertpapiere wurden ursprünglich am 06. Mai 2024 als eingeschränkte Aktienzuteilungen/Vergütung erworben, was bedeutet, dass die Aktien nun von Beschränkungen befreit werden und gemäß Regel 144 öffentlich weiterverkauft werden dürfen.

Jüngstes Verkaufsmuster: Derselbe Trust (und Richard D Moss persönlich) hat in den letzten drei Monaten 39.734 Aktien verkauft und damit kumulierte Bruttoerlöse von etwa 479.000 $ erzielt (Summe der aufgeführten Einzeltransaktionen). Die Einreichung nennt keine wesentlichen nicht öffentlichen Informationen oder Details zu einem Handelsplan; der Unterzeichner bestätigt die Einhaltung von Regel 144 und das Fehlen nicht offengelegter negativer Informationen.

Für Investoren signalisiert die Transaktion eine fortgesetzte Liquiditätsaktivität von Insidern, ist jedoch für sich allein genommen nicht groß genug, um den Streubesitz zu beeinflussen oder nennenswerten Marktdruck auszuüben. Dennoch könnte die Häufigkeit der Verkäufe als leicht negatives Sentiment interpretiert werden, sollte das Muster anhalten.

Free Writing Prospectus to Preliminary Pricing Supplement No. 9,169

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 1, 2025; Filed pursuant to Rule 433

Morgan Stanley

SPUMP40 Fixed Income Buffered Auto-Callable Securities due July 16, 2030

This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.

Terms

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Underlier:

S&P® U.S. Equity Momentum 40% VT 4% Decrement Index (SPUMP40)

Automatic early redemption:

If, on any redemption determination date, the closing level of the underlier is greater than or equal to the call threshold level, the securities will be automatically redeemed. No further payments will be made on the securities once they have been automatically redeemed.

Call threshold level:

100% of the initial level

Redemption determination dates:

Beginning after 1 year, monthly

Fixed coupon:

7.00% per annum

Coupon payment dates:

Monthly

Buffer amount:

15% (85% maximum loss)1

Pricing date:

July 11, 2025

Final observation date:

July 11, 2030

Maturity date:

July 16, 2030

CUSIP:

61778NFL0

Estimated value:

$920.70 per security, or within $55.00 of that estimate

Preliminary pricing supplement:

https://www.sec.gov/Archives/edgar/data/895421/000183988225036014/ms9169_424b2-19678.htm

1All payments are subject to our credit risk

 

Hypothetical Payment at Maturity1

(if the securities have not been automatically redeemed)

% Change in Closing Level of the Underlier

Payment at Maturity per Security (excluding the fixed coupon payable at maturity)

+100.00%

$1,000.00

+80.00%

$1,000.00

+60.00%

$1,000.00

+40.00%

$1,000.00

+20.00%

$1,000.00

0.00%

$1,000.00

-10.00%

$1,000.00

-15.00%

$1,000.00

-16.00%

$990.00

-20.00%

$950.00

-40.00%

$750.00

-60.00%

$550.00

-80.00%

$350.00

-100.00%

$150.00

 


 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

Underlier(s)

For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

Risks Relating to an Investment in the Securities

The securities provide for only the minimum payment at maturity.

Investors will not participate in any appreciation in the value of the underlier.

The securities are subject to early redemption risk.

The market price of the securities may be influenced by many unpredictable factors.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

The securities will not be listed on any securities exchange and secondary trading may be limited.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier, the securities are subject to the following risks, as discussed in more detail in the accompanying index supplement. The accompanying index supplement refers to the underlier as the “Index.”

oNo assurance can be given that the investment strategy used to construct the Index will achieve its intended results or that the Index will be successful or will outperform any alternative index or strategy that might reference the Index Components.

oThe decrement of 4% per annum will adversely affect the performance of the Index in all cases, whether the Index appreciates or depreciates.

oThe Index is subject to risks associated with the use of significant leverage.

oThe Index may not be fully invested.

oThe Index was established on March 14, 2022 and therefore has very limited operating history.

oAs the Index is new and has very limited historical performance, any investment in the Index may involve greater risk than an investment in an index with longer actual historical performance and a proven track record.

oHigher future prices of the futures contract to which the Index is linked relative to its current prices may adversely affect the value of the Index and the value of instruments linked to the Index.

oSuspensions or disruptions of market trading in futures markets could adversely affect the price of instruments linked to the Index.

oLegal and regulatory changes could adversely affect the return on and value of your securities.

oThe E-mini Russell 2000 futures contracts are one of the Index Components and are subject to risks associated with small-capitalization companies.

oAdjustments to the Index could adversely affect the value of instruments linked to the Index.

Risks Relating to Conflicts of Interest

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities–United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.

 

FAQ

How many Nature's Sunshine (NATR) shares are being sold under this Form 144?

The filing covers 1,500 common shares to be sold on or about 01 July 2025.

What is the dollar value of the proposed NATR sale?

The aggregate market value reported is $22,133.80.

Who is the seller in this Form 144 filing?

The Richard D Moss Revocable Trust (and related accounts) is the selling holder.

How many NATR shares has the trust sold recently?

The trust has disclosed sales totaling 39,734 shares over the last three months.

Does the sale materially impact Nature's Sunshine’s share count?

No. 1,500 shares equal roughly 0.008% of the 18.35 million shares outstanding.

Why are the shares eligible for resale now?

They were restricted stock grants acquired on 06 May 2024 that have met Rule 144 holding requirements.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

224.20B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
Link
United States
NEW YORK